Ignite Creation Date:
2025-12-24 @ 3:50 PM
Ignite Modification Date:
2025-12-24 @ 3:50 PM
Study NCT ID:
NCT01217892
Status:
COMPLETED
Last Update Posted:
2014-10-27
First Post:
2010-10-07
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Evaluation of Dapagliflozin Taken Twice-daily
Sponsor:
AstraZeneca
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2010-11
Start Date Type:
None
Primary Completion Date:
2011-08
Primary Completion Date Type:
ACTUAL
Completion Date:
2011-08
Completion Date Type:
ACTUAL
First Submit Date:
2010-10-07
First Submit QC Date:
None
Study First Post Date:
2010-10-08
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-01-21
Results First Submit QC Date:
None
Results First Post Date:
2013-11-01
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2014-10-16
Last Update Post Date:
2014-10-27
Last Update Post Date Type:
ESTIMATED